EXAS - Exact Sciences GAAP EPS of -$0.60 misses by $0.11 revenue of $637.52M beats by $10.71M
2024-05-08 16:08:34 ET
More on Exact Sciences
- Exact Sciences: Cancer Battle Continues, Shares Likely To Plateau
- Exact Sciences Corporation (EXAS) Q4 2023 Earnings Call Transcript
- Exact Sciences Corporation 2023 Q4 - Results - Earnings Call Presentation
- Exact Sciences Q1 2024 Earnings Preview
- Exact Sciences names Aaron Bloomer as CFO